JGC
WST icon

J. Goldman & Co’s West Pharmaceutical WST Stock Holding History

J. Goldman & Co’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-163,809
Closed -$35.8M – 630
2025
Q2 		$35.8M Buy
+163,809
New +$35M 0.86% 19
2023
Q1 		– Sell
-3,140
Closed -$739K – 502
2022
Q4 		$739K Buy
+3,140
New +$744K 0.04% 247

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

J. Goldman & Co's WST Position: Q3 2025 in Review

J. Goldman & Co sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 163,809 shares — an estimated $35.8M sold.

J. Goldman & Co first reported a position in WST in Q4 2022 and held it in 2 quarters. The position peaked at $35.8M in Q2 2025. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • J. Goldman & Co reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • J. Goldman & Co sold 163,809 West Pharmaceutical shares in Q3 2025, an estimated $35.8M.
  • J. Goldman & Co first reported a position in West Pharmaceutical in Q4 2022 and held it in 2 quarters.
  • J. Goldman & Co's West Pharmaceutical position peaked at $35.8M in Q2 2025.
  • 758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on J. Goldman & Co's 13F filing for Q3 2025, filed 14 Nov 2025.